Recent evidences indicate that HPC may be the cell of origin in certain subtypes of CCA such as cholangiolocarcinoma and the so-called mixed-type CCA or HCC tumors, such as CK19+ HCC [13, 16–18]. The gene discussed is KRT19; the disease is cholangiocarcinoma.